HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

4-Methylpyrazole

HCID 3406
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
7554-65-6
Standard SMILES
Cc1cn[nH]c1
InChIKey
RIKMMFOAQPJVMX-UHFFFAOYSA-N
Molecular formula
C4H6N2
Average molar mass
82.1 g/mol
Monoisotopic mass
82.0530982

Overview

Fomepizole is a member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4. It has a role as an antidote, a protective agent and an EC 1.1.1.1 (alcohol dehydrogenase) inhibitor. It derives from a hydride of a 1H-pyrazole.

Names & identifiers

Preferred name
4-Methylpyrazole
IUPAC
4-methyl-1H-pyrazole
English name
4-Methylpyrazole
Molecular formula
C4H6N2
Molecular weight
82.1

Names & synonyms

4-Methylpyrazolefomepizole7554-65-61H-Pyrazole, 4-methyl-Fomepizol4-MethylpyrazolFomepizolumCHEBI:514183LCM6L2BYNSC-760365DTXSID30406494 Methylpyrazole
Show more names
Antizol-VetAKOS B014452Antizol (TN)4-Fomepizole4-methyl-pyrazol
4 Methylpyrazole MonohydrochlorideRefChem:58530DTXCID1020649V03AB34231-445-04-Methyl-1H-pyrazoleAntizolFomepizol [INN-Spanish]

Database identifiers

CAS
7554-65-6
PubChem CID
3406
DTXSID
DTXSID3040649
ChEMBL
CHEMBL1308
ChEBI
CHEBI:5141
UNII
83LCM6L2BY
EC Number
231-445-0
Nikkaji
J35.396E

Properties

Computed structural propertiesFilling in

XLogP
1.4
Topological polar surface area
28.7 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
1
Rotatable bonds
0
Heavy atoms
6
Formal charge
0
Complexity
44.8

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceutical

Pharmaceuticals -> Listed in ZINC15

SpringerMaterials PropertiesOptical coefficient
LogP0.9
Solubility5.59e+02 g/L
Human Drugs · 3 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Antidotes and other substances used in poisonings > Specific

Animal DrugsFDA approved animal drugs -> Active ingredient
Melting Point25 °C
Physical DescriptionSolid

Physicochemical properties

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 154 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationREACH registered substance: 4-methylpyrazole (EC: 231-445-0)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Fomepizole

Ambiguous-DILI-concern

3

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Safety data

F
10-23
PPE
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
wgk
3
rtecs
UQ7350000
ridadr
2810
hs_code
29331990

Chemistry & industry

Pharmacology

ATC Code · 3 items

V - Various

QV - Various

V03AB34

Pharmacodynamics · 1 item

Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites. Ethylene glycol is first metabolized to glycoaldehyde which then undergoes further oxidation to glycolate, glyoxylate, and oxalate. Glycolate and oxalate are primarily responsible for metabolic acidosis and renal damage seen in ethylene glycol toxicity. {01}{03} Methanol is first metabolized to formaldehyde and then undergoes subsequent oxidation via formaldehyde dehydrogenase to become formic acid. It is formic acid that is primarily responsible for the metabolic acidosis and visual disturbances that are associated with methanol poisoning.

Mechanism of Action · 1 item

Antizol (fomepizole) is a competitive inhibitor of alcohol dehydrogenase. Alcohol dehydrogenase catalyzes the oxidation of ethanol to acetaldehyde. Alcohol dehydrogenase also catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.

Biological Half-LifeThe plasma half-life of Antizol varies with dose, even in patients with normal renal function, and has not been calculated.
Metabolism/Metabolites · 1 item

Primarily hepatic. the primary metabolite is 4-carboxypyrazole (approximately 80 to 85% of an administered dose). Minor metabolites include 4-hydroxymethylpyrazole and the N -glucuronide conjugates of 4-carboxypyrazole and 4-hydroxymethylpyrazole.

FDA Pharmacological Classification · 6 items

83LCM6L2BY

FOMEPIZOLE

Established Pharmacologic Class [EPC] - Antidote

Fomepizole is an Antidote.

FOMEPIZOLE

Antidote [EPC]

MeSH Pharmacological Classification · 2 items

Related reactions

110 records
New reaction record
HRID 32766 reaction equation
HRID 32766As reactant
HRID 32767 reaction equation
HRID 32767As reactant
HRID 61031 reaction equation
HRID 61031As reactant
HRID 72269 reaction equation
HRID 72269As reactant
HRID 114768 reaction equation
HRID 114768As reactant
HRID 166309 reaction equation
HRID 166309As reactant
HRID 187612 reaction equation
HRID 187612As reactant
HRID 191495 reaction equation
HRID 191495As reactant
PreviousPage 1 of 14

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Melting point
13 °C · 13°C
Boiling point
99 · 99-100 °C6 mm Hg(lit.)
Density
0.993 g/mL · 0.993 g/mL at 25 °C(lit.)
vapor pressure
7.136 · 7.136-87.85Pa at 20-50℃
refractive index
20 · n20/D 1.495(lit.)
Flash point
205 °F · 205 °F
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
solubility
soluble
pka
14.95 · 14.95±0.50(Predicted)
form
Liquid After Melting
color
Clear colorless to yellow
Specific Gravity
0.993 · 0.993
Water Solubility
soluble
Sensitive
Hygroscopic
Merck
14 · 14,4226
BRN
105204 · 105204
InChI
1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6)
InChIKey
RIKMMFOAQPJVMX-UHFFFAOYSA-N
SMILES
Cc1cn[nH]c1
LogP
1.097 · 1.097 (est)
CAS DataBase Reference
7554 · 7554-65-6(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
83 LCM6L2BY · 83LCM6L2BY
ATC code
3 AB34 · V03AB34
NIST Chemistry Reference
4 · 4-methylpyrazole(7554-65-6)
UNSPSC Code
12352100 · 12352100
NACRES
22 · NA.22
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P264-P270-P301+P312-P302+P352-P305+P351+P338
target organs
Respiratory system
PPE
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Hazard Codes
Xn
Risk Statements
22 · 22-36/37/38
Safety Statements
26 · 26-36-24/25
RIDADR
2810 · 2810
WGK Germany
3 · 3
RTECS
7350000 · UQ7350000
F
10 · 10-23
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29331990 · 29331990
Storage Class
10 · 10 - Combustible liquids
Hazard Classifications
4 OralEye · Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Toxicity
50 · LD50 (7 days) in mice, rats (mmol/kg): 3.8, 3.8 i.v.; 7.8, 6.5 orally (Magnusson)
REACH Registrations
Inactive
Toxicity
LD50 (7 days) in mice, rats (mmol/kg): 3.8, 3.8 i.v.; 7.8, 6.5 orally (Magnusson)
risk_code
22-36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
26-36-24/25
hazard_class
6.1(b)
Storage Class
10 - Combustible liquids
packing_group
III
target organs
Respiratory system
Hazard statements
H302-H315-H319-H335
REACH Registrations
Inactive
Hazard Classifications
Acute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
Precautionary statements
P261-P264-P270-P301+P312-P302+P352-P305+P351+P338

Agents counteracting or neutralizing the action of POISONS.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Absorption, Distribution and Excretion · 3 items

Rapid and complete

In healthy volunteers, only 1-3.5% of the administered dose of Antizol® (7-20 mg/kg oral and IV) was excreted unchanged in the urine, indicating that metabolism is the major route of elimination. In humans, the primary metabolite of Antizol® is 4-carboxypyrazole (approximately 80-85% of administered dose), which is excreted in the urine. The metabolites of Antizol® are excreted renally.

0.6 to 1.02 L/kg

Cellular LocationsCytoplasm
Applications · 7 items

DescriptionFomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes metabolism of ethylene glycol and methanol to toxic metabolites. At 10 μM in monkeys, it can prevent the formation of toxic alcohol metabolites that generate metabolic acidosis. This compound is typically used as an antidote for ethylene glycol or methanol poisoning.

DescriptionFomepizole is the first drug indicated as an antidote for ethylene glycol poisoning (it has also shown promise as a treatment for methanol poisoning). Fomepizole is 4-methyl-1H-pyrazole active as a synthetic alcohol dehydrogenase inhibitor, blocking the formation of toxic ethylene glycol metabolites which are responsible for a severe metabolic acidosis and renal failure. In limited human studies, it reversed the toxicity of potentially lethal doses of ethylene glycol. The main urinary metabolite has been reported to be 4-carboxypyrazole by oxidation of the methyl group. Compared with the current treatment (ethanol), the duration of action is longer and the safety is improved, with no toxic effects reported.

UsesFomepizole (4-Methylpyrazole) can be used as: A reactant to prepare 4-methyl-1-phenyl-1H-pyrazole by reacting with bromobenzene via N-arylation using a copper catalyst. A starting material for the synthesis of 4-methyl-3(5)-nitropyrazole by nitration. A ligand in the preparation of gallium(III) complex of 4-methylpyrazole as potential antitumor and antiviral agent.

UsesUseful as an antidote in methanol and ethylene glycol poisoning.

UsesAntidote in methanol or ethylene glycol poisoning;Alcohol dehydrogenase inhibitor

Usesantidote to ethylene glycol or methanol poisoning

General Description4-Methylpyrazole inhibits CYP2E1 activity. It also acts as alcohol dehydrogenase inhibitor.

Upstream & downstream products

Upstream raw materials

Sulfuric acidIsobutyraldehydeSodium iodideHydrazine hydrate1,1,3,3-Tetraethoxy-2-methylpropaneMethallyl acetate4-Methylpyrazole-5-carboxylic acid3-Amino-2-methylacrylaldehydeformamideHydrazine sulfate

Downstream products

1H-Pyrazole,4-methyl-1-nitro-(9CI)Antihistamine-1

Additional notes

DefinitionChEBI: A member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4.